Frequently Asked Questions
The U.S is the dominating region of the North America Enzyme Immunoassay (EIA) Reagents and Devices Market.
The North America Enzyme Immunoassay (EIA) Reagents and Devices Market growth rate will be 3.10% by 2028.
The increase in the elderly population. Furthermore, the rise in the incidence of chronic conditions, like cancer, infections, cardiovascular diseases, diabetes mellitus, autoimmune diseases and nephrological diseases are the growth drivers of the North America Enzyme Immunoassay (EIA) Reagents and Devices Market.
The technology, product, application and end user are the factors on which the North America Enzyme Immunoassay (EIA) Reagents and Devices Market research is based.
The major companies in the North America Enzyme Immunoassay (EIA) Reagents and Devices Market are Thermo Fisher Scientific, QIAGEN, DiaSorin S.p.A., SYSMEX Corporation, Phoenix Pharmaceuticals., Abbott, Sartorius AG, Ortho Clinical Diagnostics, F. Hoffmann-La Roche Ltd, VirtualExpo, bioMérieux SA, Danaher, Siemens, DuPont., DSM, Novozymes, Bio-Techne., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Quidel Corporation., PerkinElmer Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BD, Merck KGaA.
